Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.
Castellazzi M, Bellini T, Trentini A, Delbue S, Elia F, Gastaldi M, Franciotta D, Bergamaschi R, Manfrinato MC, Volta CA, Granieri E, Fainardi E.
Castellazzi M, et al. Among authors: elia f.
Dis Markers. 2016;2016:8434209. doi: 10.1155/2016/8434209. Epub 2016 Jun 2.
Dis Markers. 2016.
PMID: 27340316
Free PMC article.